RELAPSING MULTIPLE SCLEROSIS
Clinical trials for RELAPSING MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new injection tame relapsing MS?
Disease control Not yet recruitingThis early-stage trial is testing an investigational drug called RO7845860, given as an injection under the skin, in people with relapsing multiple sclerosis (MS). The main goals are to check the drug's safety, how the body handles it, and its effects on immune cells. The study w…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
MS patients switch drugs to save immune defenses
Disease control Not yet recruitingThis study follows 115 adults with multiple sclerosis who are switching from ocrelizumab to ofatumumab because their antibody levels dropped. Researchers want to see if the switch stops or slows that decline over 24 months. The goal is to better manage immune health while still t…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New study aims to find which MS drug better fights fatigue
Knowledge-focused Not yet recruitingThis study will follow 100 adults with multiple sclerosis who are starting either teriflunomide or dimethyl fumarate as part of their routine care. Over 12 months, researchers will measure how well participants can walk and think during sustained activities, along with their repo…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS
Sponsor: TC Erciyes University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC